AXL and breast cancer: In the mouse xenograft model of the radioresistant MMTV-pyMT breast cancer, the genetic knockout of Axl resulted in reduced growth and increased sensitivity to radiation therapy and immunotherapy, which was associated with about twenty-fold increased CD8+ T-cell response [56].